Skip to main content
Clinical Trials/NCT07021105
NCT07021105Enrolling By InvitationNot Applicable

COMPARISON OF ERECTOR SPINAE PLANE BLOCK, QUADRATUS LUMBORUM BLOCK, AND TRANSVERSUS ABDOMINIS PLANE BLOCK IN POSTOPERATIVE PAIN MANAGEMENT IN GYNECOLOGICAL ABDOMINAL SURGERIES

Cukurova University1 site in 1 country80 target enrollmentStarted: December 6, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Enrolling By Invitation
Enrollment
80
Locations
1
Primary Endpoint
morphine consumption in the postoperative period

Study Overview

Brief Summary

This study compares the effects of transversus abdominis plane (TAP) block, quadratus lumborum block (QLB), and erector spinae plane block (ESP) on postoperative morphine consumption, pain scores, patient satisfaction, and side effects in patients undergoing gynecological abdominal laparotomy surgeries.

Detailed Description

Patients will be randomly assigned into four groups using a computer-generated randomization method. According to group allocation, patients will receive the following interventions before extubation under ultrasound (US) guidance except control group:

Group E (n=20): Bilateral erector spinae plane (ESP) block will be performed with 40 ml of 0.25% bupivacaine (20 ml on each side) at the T12 level, approximately 3-4 cm laterally from the midline, in the neurofascial plane between the transverse processes and the erector spinae muscle.

Group Q (n=20): Bilateral quadratus lumborum block (QLB) will be performed with 40 ml of 0.25% bupivacaine (20 ml on each side), placed between the psoas major and quadratus lumborum muscles under US guidance, between the iliac crest and the 12th rib.

Group T (n=20): Bilateral transversus abdominis plane (TAP) block will be performed with 40 ml of 0.25% bupivacaine (20 ml on each side) in the neurofascial plane between the internal oblique and transversus abdominis muscles.

Group C (Control group, n=20): No block will be applied, only the standard intravenous patient-controlled analgesia (PCA) protocol will be used.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Sequential
Primary Purpose
Treatment
Masking
Single (Investigator)

Eligibility Criteria

Ages
18 Years to 69 Years (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •aged between 18 and 69 years, with ASA 1-2 score scheduled to undergo major gynecological abdominal surgery

Exclusion Criteria

  • •ASA score 3 or above, patients younger than 18 or older than 69 years, patients with bleeding disorders or using anticoagulants, patients with a body mass index over 40, patients with known allergies to any drugs used in the study, and patients who could not or did not wish to use Patient-Controlled Analgesia (PCA) device

Arms & Interventions

Group Q

Active Comparator

Group QLB & ESP, TAP, Control

Intervention: ESP Plane block (Procedure)

Group Q

Active Comparator

Group QLB & ESP, TAP, Control

Intervention: TAP Block (Procedure)

Group T

Active Comparator

Group T & ESP, QLB, Control

Intervention: ESP Plane block (Procedure)

Group T

Active Comparator

Group T & ESP, QLB, Control

Intervention: QLB plane block (Procedure)

Group C

No Intervention

Group C & ESP, QLB, TAP

Group E

Active Comparator

Group ESP & QLB, TAP, Control

Intervention: QLB plane block (Procedure)

Group E

Active Comparator

Group ESP & QLB, TAP, Control

Intervention: TAP Block (Procedure)

Group T

Active Comparator

Group T & ESP, QLB, Control

Intervention: No intervention (Other)

Group Q

Active Comparator

Group QLB & ESP, TAP, Control

Intervention: No intervention (Other)

Group E

Active Comparator

Group ESP & QLB, TAP, Control

Intervention: No intervention (Other)

Outcomes

Primary Outcomes

morphine consumption in the postoperative period

Time Frame: For postoperative 24 hours

Thus the primary aim of this study was to assess the morphine consumption in the postoperative period

Secondary Outcomes

  • pain score (VAS=0-10), patient satisfaction (0-10), the need for rescue analgesia (mg) and side effects(For postoperative 24 hours)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Hakki Unlugenc

Prof Dr

Cukurova University

Study Sites (1)

Loading locations...

Similar Trials